Prices delayed by 15 minutes
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 16, 2026 | 146.58 | 149.30 | 146.12 | 147.68 | 5m |
| September 15, 2026 | 144.00 | 146.35 | 142.94 | 146.30 | 5m |
| September 14, 2026 | 144.26 | 146.75 | 143.71 | 146.41 | 5m |
| September 11, 2026 | 145.24 | 145.99 |
Based on reports through December 31, 2025
Gilead is built on antivirals: HIV supplies the revenue, oncology the hope for the future.
The core is HIV treatment and prevention. That is a durable market: therapy is lifelong, adherence is high, and prevention widens the population beyond those already infected. The company steadily extends the franchise's commercial life with longer-acting formulations.
The hepatitis C story is an important lesson in the company's biography: those medicines cured the disease outright, and revenue collapsed once the queue of patients was treated. A rare case where a drug's effectiveness destroyed its own market.
The replacement direction is oncology, including cell therapy after the Kite acquisition. It has not yet replaced the core income, and its progress is the main focus for investors. Gilead pays a substantial dividend.
Address:333 LAKESIDE DR, FOSTER CITY, CA, 94404, US
| 226m |
| HALOHalozyme Therapeutics, Inc. | 109.72 | +1.18 % | 211m |
| TECHBio-Techne Corp | 72.41 | +0.11 % | 192m |
| NBIXNeurocrine Biosciences, Inc. | 151.41 | +127.80 % | 173m |
| RGENRepligen Corporation | 178.19 | +3.05 % | 165m |
| 143.50 |
| 143.72 |
| 4m |
| September 10, 2026 | 145.07 | 145.91 | 143.67 | 144.81 | 6m |
| September 09, 2026 | 145.46 | 147.68 | 145.00 | 145.65 | 5m |
| September 08, 2026 | 146.98 | 148.65 | 145.45 | 146.64 | 6m |
| September 04, 2026 | 149.23 | 151.19 | 149.23 | 151.00 | 6m |
| September 03, 2026 | 150.67 | 151.48 | 148.41 | 151.22 | 4m |
| September 02, 2026 | 150.00 | 152.55 | 148.83 | 149.61 | 5m |
| September 01, 2026 | 148.52 | 149.96 | 146.92 | 149.92 | 5m |
| August 31, 2026 | 144.23 | 147.22 | 143.18 | 146.34 | 7m |
| August 28, 2026 | 149.47 | 149.47 | 144.88 | 145.68 | 4m |
| August 27, 2026 | 147.30 | 149.11 | 146.01 | 148.86 | 5m |
| August 26, 2026 | 148.00 | 149.62 | 147.00 | 148.09 | 5m |
| August 25, 2026 | 146.60 | 148.94 | 145.58 | 148.77 | 5m |
| August 24, 2026 | 145.93 | 146.84 | 144.59 | 146.74 | 6m |
| August 21, 2026 | 144.52 | 147.91 | 143.50 | 146.12 | 5m |
| August 20, 2026 | 146.69 | 146.82 | 143.19 | 143.44 | 7m |
| August 19, 2026 | 145.10 | 148.97 | 144.30 | 147.60 | 7m |